45 citations
,
March 2001 in “Journal of Investigative Dermatology” A new protein, mK6irs, is found in specific hair layers and may help understand hair growth and diseases.
May 2025 in “International Journal of Trichology” Routine monitoring isn't needed for healthy patients on low-dose oral minoxidil, but is advised for those with kidney issues.
July 2024 in “Journal of Investigative Dermatology” DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.
June 2017 in “Journal of The American Academy of Dermatology” Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.
Topical minoxidil is the safest hair loss treatment for dialysis patients.
5 citations
,
May 2018 in “Veterinary dermatology” Gluconolactone products can significantly reduce skin scaling in golden retrievers with ARCI.
April 2018 in “Journal of Investigative Dermatology” Minoxidil didn't significantly increase hair growth in minipigs.
March 2026 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.
7 citations
,
July 2021 in “Molecules/Molecules online/Molecules annual” The method can measure vitamin B3 levels in human hair accurately.
July 2025 in “The Journal of Dermatology” 5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.
July 2025 in “Skin Health and Disease” PRP is a good alternative or addition to minoxidil for treating hair loss.
June 2025 in “Formosa Journal of Sustainable Research” Mangkokan leaf extract can fight bacteria and may help prevent hair loss and treat infections.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” PRP may be more effective and satisfying for hair regrowth than minoxidil, with similar safety.
1 citations
,
December 2016 in “Govar-î zanko-î silêmanî. Beş-i A. Zaniste siruştîye” Traditional Kurdistan plant extracts can promote hair growth like Minoxidil.
December 2023 in “International Journal of Advanced Research in Science, Communication and Technology” A reliable method was created to measure Minoxidil and Finasteride in a solution.
3 citations
,
February 2021 in “Medical journal, Armed Forces India” Combination therapy promotes better hair growth and density.
February 2024 in “Dermatology Reports” Microneedling combined with minoxidil is more effective and safe for hair growth in men with hair loss.
January 2025 in “The Egyptian Journal of Hospital Medicine” Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.
May 2026 in “Reactions Weekly”
December 2024 in “Journal of the European Academy of Dermatology and Venereology” Sublingual and oral minoxidil are equally effective for hair growth, but sublingual causes fewer palpitations.
9 citations
,
June 2011 in “International Journal of Cosmetic Science” The new mild shampoo helped prevent hair loss in the subjects.
January 2025 in “Dermatology Practical & Conceptual” Topical finasteride is as effective and safe as minoxidil for treating female pattern hair loss.
5 citations
,
February 2025 in “Pediatric Dermatology” Ritlecitinib was generally well tolerated in children with alopecia areata.
1 citations
,
March 2000 in “CRC Press eBooks”
February 2024 in “Jurnal Kesehatan Yamasi Makassar” Pondoh salak fruit peel extract is effective in shampoo and has strong antimicrobial properties.
May 2013 in “DOAJ (DOAJ: Directory of Open Access Journals)” The multimodal microemulsion with minoxidil, diclofenac, and tea tree oil is more effective for hair growth than minoxidil alone.
57 citations
,
August 2003 in “British Journal of Dermatology” Minoxidil and pyrithione zinc combo most effectively increases hair density.
January 2008 in “Abstracts” Minoxidil sulfate gel can be used to treat hair loss.
April 2024 in “Journal of translational medicine” MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.
June 2024 in “Archives of dermatological research” Targeted testing for telogen effluvium patients can save healthcare costs.